These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 6126866)

  • 41. Interaction of MIF-I or alpha-MSH with D-amphetamine or chlorpromazine on thermoregulation and motor activity of rats maintained at different ambient temperatures.
    Yehuda S; Kastin AJ
    Peptides; 1980; 1(3):243-8. PubMed ID: 6112734
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of melanocyte-stimulating hormone (MSH) and melatonin on passive avoidance and on an emotional response.
    Datta PC; King MG
    Pharmacol Biochem Behav; 1977 Apr; 6(4):449-52. PubMed ID: 882581
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Effects of Pro-Leu-Gly-NH2 (MIF) on the antinociceptive and thermoregulatory actions of morphine and oxotremorine.
    Slater P; Dickinson SL
    J Pharm Pharmacol; 1982 Feb; 34(2):113-5. PubMed ID: 6121869
    [No Abstract]   [Full Text] [Related]  

  • 44. Naloxone-like protective effect of MIF-1 (Pro-Leu-Gly-NH2) on hemorrhagic shock.
    Krause W; Nieber K; Ehrlich A; Bienert M; Oehme P
    Pharmazie; 1984 May; 39(5):352-3. PubMed ID: 6147863
    [No Abstract]   [Full Text] [Related]  

  • 45. Cyclic analogues of Tyr-W-MIF-1 with prolonged analgesic activity and potency comparable to DAMGO and morphine.
    Zadina JE; Kastin AJ; Hackler L; Chang SL
    Peptides; 1994; 15(8):1567-9. PubMed ID: 7700858
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Analgesia and the blood-brain barrier transport system for Tyr-MIF-1/enkephalins: evidence for a dissociation.
    Banks WA; Kastin AJ; Nager BJ
    Neuropharmacology; 1988 Feb; 27(2):175-9. PubMed ID: 2895431
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Pro-Leu-Gly-NH2 serves as a conditioned stimulus in the acquisition of conditioned tolerance.
    McLaughlin CR; Lichtman AH; Fanselow MS; Cramer CP
    Behav Neurosci; 1989 Apr; 103(2):447-51. PubMed ID: 2565116
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Differential inhibitory effects of MIF-1, Tyr-MIF-1, naloxone and beta-funaltrexamine on body rotation-induced analgesia in the meadow vole, Microtus pennsylvanicus.
    Lipa SM; Kavaliers M; Ossenkopp KP
    Peptides; 1989; 10(3):493-7. PubMed ID: 2571138
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Interactions between pineal, hypothalamus, and pituitary involving melatonin, MSH release-inhibiting factor and MSH.
    Kastin AJ; Viosca S; Nair RM; Shally AV; Miller MC
    Endocrinology; 1972 Nov; 91(5):1323-8. PubMed ID: 5072810
    [No Abstract]   [Full Text] [Related]  

  • 50. Differential effects of Tyr-MIF-1, MIF-1, and naloxone on peptide YY-induced hyperphagia.
    Hagan MM; Moss DE
    Peptides; 1994; 15(2):243-5. PubMed ID: 7911993
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Effects of neonatal treatment with Tyr-MIF-1, morphiceptin, and morphine on development, tail flick, and blood-brain barrier transport.
    Harrison LM; Zadina JE; Banks WA; Kastin AJ
    Brain Res Dev Brain Res; 1993 Oct; 75(2):207-12. PubMed ID: 7903224
    [TBL] [Abstract][Full Text] [Related]  

  • 52. New evidence that demonstrates that L-pro-L-leu-L-gly-NH2 might be the natural MIF.
    Vivas A; Celis ME
    Acta Physiol Lat Am; 1977; 27(4):177-82. PubMed ID: 31762
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Effects of MIF-I and melatonin on novelty-induced defecation and associated plasma 11-OHCS and brain catecholamines.
    Datta PC; King MG
    Pharmacol Biochem Behav; 1979 Aug; 11(2):173-81. PubMed ID: 41262
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Development of narcotic tolerance and physical dependence: effects of Pro-Leu-Gly-NH2 and cyclo (Leu-Gly).
    Bhargava HN; Walter R; Ritzmann RF
    Pharmacol Biochem Behav; 1980 Jan; 12(1):73-7. PubMed ID: 6102769
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Inhibitory influences of MIF-1 (PLG) and Tyr-MIF-1 (YPLG) on aggression and defeat-induced analgesia in mice.
    Kavaliers M; Hirst M
    Peptides; 1986; 7(6):1007-10. PubMed ID: 2882493
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Structure activity relationship studies with hypothalamic peptide hormones III. Effect of melanotropin-release inhibiting factor and analogs on tolerance to morphine in the rat.
    Bhargava HN; Kim HS
    Neuropharmacology; 1982 Sep; 21(9):917-22. PubMed ID: 6128692
    [TBL] [Abstract][Full Text] [Related]  

  • 57. CNS and pituitary effects of hypothalamic peptides and MSH.
    Kastin AJ; Miller LH; Sandman CA; Schally AV; Plotnikoff NP
    Essays Neurochem Neuropharmacol; 1977; 1():139-76. PubMed ID: 30623
    [TBL] [Abstract][Full Text] [Related]  

  • 58. In vitro studies of Tyr-MIF-1 with human lymphocytes.
    Chi DS; Strimas JH; Kastin AJ
    Brain Res Bull; 1989 Dec; 23(6):549-52. PubMed ID: 2575445
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A diurnal rhythm in melanocyte-stimulating hormone content of the rat pituitary gland and its independence from the pineal gland.
    Tilders FJ; Smelik PG
    Neuroendocrinology; 1975; 17(4):296-308. PubMed ID: 1079927
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Dopamine receptor antagonists block the effect of Tyr-MIF-1 (Tyr-Pro-Leu-Gly-NH2) on the opiate form of footshock-induced analgesia.
    Krowicki ZK
    Neuropeptides; 1991 Aug; 19(4):281-5. PubMed ID: 1681456
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.